PBH
Prestige Consumer Healthcare Inc.
NYSE · USHealthcareMedical - Distribution
$50.41+0.98%
Price as of Jul 20, 2026
PBH financials
Prestige Consumer Healthcare Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $1.1B | $1.1B | $1.1B | $1.1B |
| Cost of revenue | $514.1M | $503.3M | $500.9M | $502.4M |
| Gross profit | $574.6M | $634.5M | $624.4M | $625.3M |
| Operating expenses | $265.2M | $297.7M | $282.0M | $647.7M |
| Operating income | $309.4M | $336.8M | $342.4M | -$22.4M |
| Net income | $190.3M | $214.6M | $209.3M | -$82.3M |
| EBITDA | $331.1M | $362.0M | $373.9M | $7.9M |
| Basic EPS | $3.93 | $4.32 | $4.21 | $-1.65 |
| Diluted EPS | $3.91 | $4.29 | $4.17 | $-1.65 |
| Balance sheet | ||||
| Cash & equivalents | $63.9M | $97.9M | $46.5M | $58.5M |
| Total assets | $3.5B | $3.4B | $3.3B | $3.4B |
| Total liabilities | $1.7B | $1.6B | $1.7B | $1.9B |
| Stockholders’ equity | $1.9B | $1.8B | $1.7B | $1.4B |
| Total debt | $1.0B | $1.0B | $1.1B | $1.4B |
| Net debt | $981.6M | $946.4M | $1.1B | $1.3B |
| Cash flow | ||||
| Operating cash flow | $265.4M | $251.5M | $248.9M | $229.7M |
| Capital expenditure | -$11.2M | -$8.2M | -$9.6M | -$7.8M |
| Free cash flow | $254.2M | $243.3M | $239.4M | $221.9M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | -$156.3M | -$51.5M | -$25.0M | -$50.0M |